Site-specific, homogeneous modification of proteins through unique genetic code expansion platform
BrickBio's platform technology enables custom tailoring of any protein with homogenous, site-specific and site-selective modifications for research and therapeutic applications and enables novel classes of biologics, including multi-site bispecific antibodies.
Improve protein characteristics, such as increasing serum half-life, improved specificity, or boosted activity
RUO kits are available for a variety of applications: dye-linked, oligo-linked,
and immuno-based assays
Development of custom protein-based therapeutics or research assays to drastically improve R&D productivity
Empowering the next generation of ADCs with improved efficacy, dosage, and modification homogeneity
We are currently developing early-stage biologic therapeutic candidates with improved characteristics
Investigation of protein half-life or protein-protein interactions in vivo with high temporal control
CEO, Co-Founder,
TIGER GENE
VP, COMMERCIAL
DEVELOPMENT
SENIOR ADVISOR &
CHAIRMAN OF SAB
HEAD OF BUSINESS DEVELOPMENT
12 Gill Street, Suite 4200
Woburn, MA, 01801, USA
For any general inquiries, please fill in the following contact form:
